Abstract
We studied the expression of calcitonin (CT) and calcitonin gene-related peptide (CGRP) in 18 patients with medullary thyroid cancer (MTC) in the neoplastic (primary or metastatic) tissue by immunohistochemistry and in the plasma by radioim-munoassay. CT immunoreactivity was found in 100% of the primary and metastatic MTC, CGRP was expressed in 66% of the primary tumors and in 73% of the metastases. Both the number of positive cells and the degree of staining were always higher for CT than for CGRP staining. While plasma CT concentrations were always increased in patients with metastases, 3 patients with metastases had undetectable plasma CGRP levels. A positive correlation was found between plasma CT and CGRP levels. These data indicate that CGRP is frequently expressed in MTC sections and that plasma CGRP measurement is an additional marker for MTC, although has no advantage with respect to CT measurements in monitoring the progression of the disease.
Similar content being viewed by others
References
Amara S.G., Jonas V., Rosenfeld M.G., Ong E.S., Evans R.M. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298: 240, 1982.
Rosenfeld M.G., Mermod J.J., Amara S.G., Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W., Evans R.M. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304: 129, 1983.
Morris H.R., Panico M., Etienne T., Tippins J., Girgis S.I., MacIntyre I. Isolation and characterization of human calcitonin gene-related peptide. Nature 308: 746, 1984.
Steenbergh P.H., Hoppener J.W.M., Zandberg J., Van De Ven W.J.M., Jansz H.S., Lips C.J.M. Calcitonin gene related peptide coding sequence is conserved in the human genome and is expressed in medullary thyroid cancer. J. Clin. Endocrinol. Metab. 59: 358, 1984.
Zajac J.D., Penschow J., Mason T., Tregear G., Coghlan J., Martin T.J. Identification of calcitonin and calcitonin gene-related peptide mesenger ribonucleic acid in medullary thyroid carcinomas by hybridization histochemistry. J. Clin. Endocrinol. Metab. 62: 1037, 1986.
Hsu S.M., Raine L., Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-bioètin complex method for studying polypeptide hormones with radioim-munoassay antibodies. Am. J. Clin. Pathol. 75: 734, 1981.
Schifter S., Williams E.D., Craig R.K., Hansen H.H. Calcitonin gene-related peptide and calcitonin in medullary thyroid carcinoma. Clin. Endocrinol. 25: 703, 1986.
Girgis S.I., Stevenson J.C., Lynch C., Self C.H., Macdonald W.R., Bevis P.G.R., Wilamawansa S.J., Morris H.R., Maclntyre I. Calcitonin gene-related peptide: potent vasodilator and major product of calcitonin gene. Lancet 2: 14, 1986.
Williams E.D., Ponder B.J., Craig R.K. Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C cell hyperplasia. Clin. Endocrinol. 27: 107, 1987.
Pacini F., Elisei R., Anelli S., Basolo F., Cola A., Pinchera A. Somatostatin in medullary thyroid cancer. In vivo and in vitro studies. Cancer 63: 1189, 1989.
Mason R.T., Shulkes A., Zajac J.D., Fletcher A.E., Hardy K.J., Martin T.J. Basal and stimulated release of calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma. Clin. Endocrinol. 25: 675, 1986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pacini, F., Fugazzola, L., Basolo, F. et al. Expression of calcitonin gene-related peptide in medullary thyroid cancer. J Endocrinol Invest 15, 539–542 (1992). https://doi.org/10.1007/BF03348802
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348802